A novel imidazopyridine derivative, X22, attenuates sepsis-induced lung and liver injury by inhibiting the inflammatory response in vitro and in vivo

Xiangting Ge1 Chemical Biology Research Center, School of Pharmaceutical Sciences;2 Department of Pulmonary Medicine, The 2nd Affiliated Hospital

Zhiguo Feng1 Chemical Biology Research Center, School of Pharmaceutical Sciences

Tingting Xu2 Department of Pulmonary Medicine, The 2nd Affiliated Hospital

Beibei Wu3 Department of Pediatrics, The 2nd Affiliated Hospital, Wenzhou Medical University, Wenzhou, People’s Republic of China

Hongjin Chen1 Chemical Biology Research Center, School of Pharmaceutical Sciences

Fengli Xu3 Department of Pediatrics, The 2nd Affiliated Hospital, Wenzhou Medical University, Wenzhou, People’s Republic of China

Lili Fu1 Chemical Biology Research Center, School of Pharmaceutical Sciences

Xiaoou Shan3 Department of Pediatrics, The 2nd Affiliated Hospital, Wenzhou Medical University, Wenzhou, People’s Republic of China

Yuanrong Dai2 Department of Pulmonary Medicine, The 2nd Affiliated HospitalCorrespondence[email protected]

Yali Zhang1 Chemical Biology Research Center, School of Pharmaceutical SciencesCorrespondence[email protected]

Guang Liang1 Chemical Biology Research Center, School of Pharmaceutical Sciences

Articles from other publishers (11)